Avacta Group Plc

Avacta Group Plcverified

AVCT.L

Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays. It also develops AffiDX SARS-CoV-2 lateral flow rapid antigen tests, as well as Affimer reagents for third party products; and novel cancer immunotherapies combining proprietary platforms. The company has a research collaboration with pre|CISION technology incorporates a substrate that is sensitive ...[Read more]

Industry

Biotechnology

IPO Date

2003-09-08

Stock Exchange

LSE

Ticker

AVCT.L

The Enterprise Value as of December 2025 (TTM) for Avacta Group Plc (AVCT.L) is 345.70M

According to Avacta Group Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 345.70M. This represents a change of 68.13% compared to the average of 205.62M of the last 4 quarters.

Avacta Group Plc (AVCT.L) Historical Enterprise Value (quarterly & annually)

How has AVCT.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Avacta Group Plc over the last ten years is 151.76M. The current 345.70M Enterprise Value has changed 22.68% with respect to the historical average. Over the past ten years (40 quarters), AVCT.L's Enterprise Value was at its highest in in the June 2021 quarter at 409.76M. The Enterprise Value was at its lowest in in the June 2004 quarter at 0.

Quarterly (TTM)
Annual

Average

151.76M

Median

118.52M

Minimum

10.94M

Maximum

324.56M

Avacta Group Plc (AVCT.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Avacta Group Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.71%

Maximum Annual Enterprise Value = 324.56M

Minimum Annual Increase = -76.33%

Minimum Annual Enterprise Value = 10.94M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024173.51M-46.54%
2023324.56M3.09%
2022314.84M8.24%
2021290.86M25.75%
2020231.30M1.71%
201912.79M16.87%
201810.94M-76.33%
201746.23M-5.76%
201649.05M-22.80%
201563.53M95.92%

Avacta Group Plc (AVCT.L) Average Enterprise Value

How has AVCT.L Enterprise Value performed in the past?

The current Enterprise Value of Avacta Group Plc (AVCT.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

270.97M

5-year avg

267.01M

10-year avg

151.76M

Avacta Group Plc (AVCT.L) Enterprise Value vs. Peers

How is AVCT.L’s Enterprise Value compared to its peers?

Avacta Group Plc’s Enterprise Value is greater than PureTech Health plc (159.09M), greater than Faron Pharmaceuticals Oy (234.88M), greater than NIOX Group Plc (271.89M), greater than 4basebio PLC (94.62M), greater than Scancell Holdings plc (102.11M), greater than Fusion Antibodies plc (22.01M), greater than Sareum Holdings plc (14.40M), greater than ImmuPharma plc (30.05M), greater than Ondine Biomedical Inc. (71.33M), greater than Hemogenyx Pharmaceuticals Plc (37.91M),

Build a custom stock screener for Avacta Group Plc (AVCT.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avacta Group Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avacta Group Plc (AVCT.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avacta Group Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Avacta Group Plc's Enterprise Value?

What is the highest Enterprise Value for Avacta Group Plc (AVCT.L)?

What is the 3-year average Enterprise Value for Avacta Group Plc (AVCT.L)?

What is the 5-year average Enterprise Value for Avacta Group Plc (AVCT.L)?

How does the current Enterprise Value for Avacta Group Plc (AVCT.L) compare to its historical average?